HuGE Literature Finder
Records
1
-
1
Weight-loss response to naltrexone/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study. Diabetes, obesity & metabolism 2020 11 23 (3): 850-853. Mullally Jamie A, Chung Wendy K, LeDuc Charles A, Reid Tirissa J, Febres Gerardo, Holleran Steven, Ramakrishnan Rajasekhar, Korner Judi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: